- Home
- MPB vs ARCT Comparison
MPB vs ARCT Comparison
Compare MPB & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPB
- ARCT
- Stock Information
- Founded
- MPB 1868
- ARCT 2013
- Country
- MPB United States
- ARCT United States
- Employees
- MPB N/A
- ARCT N/A
- Industry
- MPB Major Banks
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- MPB Finance
- ARCT Health Care
- Exchange
- MPB Nasdaq
- ARCT Nasdaq
- Market Cap
- MPB 641.4M
- ARCT 298.3M
- IPO Year
- MPB N/A
- ARCT N/A
- Fundamental
- Price
- MPB $30.22
- ARCT $13.78
- Analyst Decision
- MPB Buy
- ARCT Strong Buy
- Analyst Count
- MPB 2
- ARCT 8
- Target Price
- MPB $36.00
- ARCT $52.83
- AVG Volume (30 Days)
- MPB 100.5K
- ARCT 484.1K
- Earning Date
- MPB 07-23-2025
- ARCT 08-04-2025
- Dividend Yield
- MPB 2.65%
- ARCT N/A
- EPS Growth
- MPB 23.94
- ARCT N/A
- EPS
- MPB 2.88
- ARCT N/A
- Revenue
- MPB $181,865,000.00
- ARCT $143,680,000.00
- Revenue This Year
- MPB $24.31
- ARCT N/A
- Revenue Next Year
- MPB $13.74
- ARCT $34.79
- P/E Ratio
- MPB $10.50
- ARCT N/A
- Revenue Growth
- MPB 9.21
- ARCT 15.38
- 52 Week Low
- MPB $21.11
- ARCT $8.04
- 52 Week High
- MPB $33.87
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- MPB 76.73
- ARCT 58.14
- Support Level
- MPB $28.02
- ARCT $12.65
- Resistance Level
- MPB $28.48
- ARCT $14.09
- Average True Range (ATR)
- MPB 0.62
- ARCT 0.94
- MACD
- MPB 0.35
- ARCT 0.05
- Stochastic Oscillator
- MPB 99.52
- ARCT 64.60
About MPB Mid Penn Bancorp
Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.